Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Gastric Cancer

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 29 articles:
HTML format



Single Articles


    December 2021
  1. XU Y, Lu J, Tang Y, Xie W, et al
    PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages.
    Cancer Lett. 2021;529:19-36.
    PubMed     Abstract available


  2. DU Y, Zhang JY, Gong LP, Feng ZY, et al
    Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP/VHL/HIF1alpha/VEGFA pathway.
    Cancer Lett. 2021 Dec 1. pii: S0304-3835(21)00605.
    PubMed     Abstract available


    November 2021
  3. MIYAMOTO S, Nagano Y, Miyazaki M, Nagamura Y, et al
    Integrin alpha5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma.
    Cancer Lett. 2021 Nov 12. pii: S0304-3835(21)00575.
    PubMed     Abstract available


  4. LI ZY, Xie Y, Deng M, Zhu L, et al
    c-Myc-activated intronic miR-210 and lncRNA MIR210HG synergistically promote the metastasis of gastric cancer.
    Cancer Lett. 2021 Nov 9. pii: S0304-3835(21)00572.
    PubMed     Abstract available


    October 2021
  5. ZHANG H, Ma RR, Zhang G, DongYi, et al
    Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis.
    Cancer Lett. 2021 Oct 6. pii: S0304-3835(21)00503.
    PubMed     Abstract available


    September 2021
  6. DAI W, Liu S, Zhang J, Pei M, et al
    Vorinostat triggers miR-769-5p/3p-mediated suppression of proliferation and induces apoptosis via the STAT3-IGF1R-HDAC3 complex in human gastric cancer.
    Cancer Lett. 2021 Sep 2. pii: S0304-3835(21)00437.
    PubMed     Abstract available


    August 2021
  7. SUGIMOTO A, Okuno T, Miki Y, Tsujio G, et al
    EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells.
    Cancer Lett. 2021 Aug 30. pii: S0304-3835(21)00428.
    PubMed     Abstract available


  8. JIANG L, Chen Y, Min G, Wang J, et al
    Bcl2-associated athanogene 4 promotes the invasion and metastasis of gastric cancer cells by activating the PI3K/AKT/NF-kappaB/ZEB1 axis.
    Cancer Lett. 2021 Aug 19. pii: S0304-3835(21)00409.
    PubMed     Abstract available


    July 2021
  9. LIN DC, Zheng SY, Zhang ZG, Luo JH, et al
    TRPC3 promotes tumorigenesis of gastric cancer via the CNB2/GSK3beta/NFATc2 signaling pathway.
    Cancer Lett. 2021 Jul 23. pii: S0304-3835(21)00370.
    PubMed     Abstract available


    June 2021
  10. KOH V, Chakrabarti J, Torvund M, Steele N, et al
    Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids.
    Cancer Lett. 2021 Jun 11. pii: S0304-3835(21)00292.
    PubMed     Abstract available


  11. CHEN Y, Li Y, Qi C, Zhang C, et al
    Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients.
    Cancer Lett. 2021;517:78-87.
    PubMed     Abstract available


  12. MILIOTIS C, Slack FJ
    miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.
    Cancer Lett. 2021 Jun 4. pii: S0304-3835(21)00268.
    PubMed     Abstract available


    December 2020
  13. DAVERN M, Lysaght J
    Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers.
    Cancer Lett. 2020;495:89-99.
    PubMed     Abstract available


    October 2020
  14. ZHU S, Khalafi S, Chen Z, Poveda J, et al
    Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.
    Cancer Lett. 2020;491:87-96.
    PubMed     Abstract available


  15. TANG H, Kong Y, Guo J, Tang Y, et al
    Corrigendum to "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22" [Canc. Lett. 340 (1) (Oct 28, 2013) 72-81].
    Cancer Lett. 2020 Oct 5. pii: S0304-3835(20)30356.
    PubMed    


    September 2020
  16. YANG J, Liu Z, Zeng B, Hu G, et al
    Epstein-Barr virus-associated gastric cancer: A distinct subtype.
    Cancer Lett. 2020 Sep 23. pii: S0304-3835(20)30486.
    PubMed     Abstract available


  17. MA DH, Li BS, Liu JJ, Xiao YF, et al
    Corrigendum to 'miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway'[Cancer Lett. 2017 Nov 1;408:23-32].
    Cancer Lett. 2020 Sep 22. pii: S0304-3835(20)30470.
    PubMed    


    August 2020
  18. ZENG Y, Ren M, Li Y, Liu Y, et al
    Knockdown of RhoGDI2 represses human gastric cancer cell proliferation, invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway.
    Cancer Lett. 2020 Aug 26. pii: S0304-3835(20)30368.
    PubMed     Abstract available


  19. LIU Y, Zhang X, Zhang Y, Hu Z, et al
    Corrigendum to "Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer"[Canc. Lett. 369 (2015) 58-66].
    Cancer Lett. 2020;494:3-4.
    PubMed    


    July 2020
  20. XIE S, Chang Y, Jin H, Feng Y, et al
    Non-coding RNAs in gastric cancer.
    Cancer Lett. 2020 Jul 23. pii: S0304-3835(20)30352.
    PubMed     Abstract available


    April 2020
  21. WANG J, Wu X, Dai W, Li J, et al
    The CCDC43-ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer.
    Cancer Lett. 2020 Apr 8. pii: S0304-3835(20)30159.
    PubMed     Abstract available


    March 2020
  22. WANG Y, Lu JH, Wang F, Wang YN, et al
    Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
    Cancer Lett. 2020;473:74-89.
    PubMed     Abstract available


  23. TAM BY, Chiu K, Chung H, Bossard C, et al
    The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
    Cancer Lett. 2020;473:186-197.
    PubMed     Abstract available


  24. ZHAO M, Hou Y, Du YE, Yang L, et al
    Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism.
    Cancer Lett. 2020 Mar 3. pii: S0304-3835(20)30109.
    PubMed     Abstract available


    February 2020
  25. PAN H, Pan J, Chen P, Gao J, et al
    Circular RNA circUBA1 promotes gastric cancer proliferation and metastasis by acting as a competitive endogenous RNA through sponging miR-375 and regulating TEAD4.
    Cancer Lett. 2020 Feb 19. pii: S0304-3835(20)30085.
    PubMed     Abstract available


    January 2020
  26. BAROK M, Le Joncour V, Martins A, Isola J, et al
    ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer.
    Cancer Lett. 2020 Jan 2. pii: S0304-3835(19)30659.
    PubMed     Abstract available


    December 2019
  27. LU J, Wang YH, Yoon C, Huang XY, et al
    Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis.
    Cancer Lett. 2019 Dec 4. pii: S0304-3835(19)30602.
    PubMed     Abstract available


    October 2019
  28. TELLI TA, Bregni G, Camera S, Deleporte A, et al
    PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.
    Cancer Lett. 2019 Oct 25. pii: S0304-3835(19)30539.
    PubMed     Abstract available


    February 2019
  29. KOEMANS WJ, Chalabi M, van Sandick JW, van Dieren JM, et al
    Beyond the PD-L1 horizon: In search for a good biomarker to predict success of immunotherapy in gastric and esophageal adenocarcinoma.
    Cancer Lett. 2019;442:279-286.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: